Toronto Medical Company Seeks $10 Billion Dollar Investment

Share Article

Saringer Life Science Technologies Inc. (SLST Inc.) is seeking a major investment in order to expand their medical technology company. Business experts claim that this is one of the biggest and most lucrative propositions in Saringer’s history and that the company shows an enormous potential for return.

Sequential Compression Pump

The Venowave is a sequential compression pump that uses a unique patented wave-form motion to increase circulation.

Saringer Life Science Technologies a medical device company providing innovative therapeutic solutions for patients.

Saringer Life Science Technologies Inc. (SLST) is making headlines today as the Canadian manufacturer and distributor of medical devices is seeking an investment to fund a colossal business expansion plan. Launched in 2007, SLST has focused its efforts on two of its most advanced medical innovations to date; The Venowave VW5 and the ICE-O-therm. After years of clinical studies and product testing, both products use the latest state of the art technology (IP protected) and are ready to be commercialized. The products have a broad range of approved indications including pain treatment, preventing blood clotting or Deep Vein Thrombosis (DVT), and a broad range of vascular conditions including the most severe; Post Thrombotic Syndrome (PTS). Most recently scientists are studying the Venowave and its ability to heal chronic diabetic foot sores after an impressive case study was conducted with a 100% success rate. Many of these conditions are largely unmet clinical needs and alternative treatments are scarce.

“We’re definitely on the verge of reaching one of our biggest milestones yet,” exclaims Saringer. Although the majority of investor dollars will go towards expansion and revenue generating initiatives, some will also go towards Saringer’s most recent focus: how the Venowave VW5- a sequential compression pump that attaches to the back of the calf in order to increase circulation - can heal diabetic foot ulcers. “It’s time to take things to the next level and find a cure for chronic diabetic foot ulcers.”

To date, the company has published four major clinical studies in conjunction with McMaster University, a world leading research institution located in Hamilton ON Canada, and continue to conduct further studies, particularly focused in the field of wound care intervention, deep vein thrombosis prevention and swollen legs due to vascular insufficiencies.

Saringer Life Science Technologies Inc. is a privately-owned company that was founded by engineer/inventor, John Saringer. John works extensively with leading physicians/surgeons in the development of new and improved medical treatment devices in the fields of DVT prevention, vascular solutions, wound healing intervention and pain management. For more information, please contact john(at)saringer(dot)com or call 905.888.1888.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Saringer LIfe Science Technologies Inc.

(905) 888-1888
Email >
Visit website